(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ORIEN AVATAR

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ORIEN AVATAR

ST13

US500000086741885

Classe

9, 42

Pedido

86741885

Registro

5125315

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

40

Atualização mais recente

18/01/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 42

Data de depósito

31/08/2015

Data de registro

17/01/2017

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

11/07/2023

Última transação

18/01/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

702

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

31/10/2016

Primeiro uso no comércio

31/10/2016

Código do desenho

4

Tipo de titular

03

Localização do titular

Hudson, FL

Examinador

BROWN,TINA

Unidade examinadora

M90

Localização atual

TMO LAW OFFICE 118

Titulares e representantes

Titulares

M2GEN, CORP.
M. C. (pessoa física)

Representantes

Karen K. Won Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.

Classificação técnica

Classes Nice

Classe 9Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Network-centric computer software for use in the fields of biomedical research and healthcare informaticscustomized software designed for use by biopharmaceutical companies to integrateanalyze and share biomedicalclinical triallaboratory research data and healthcare information to enhance discoverydevelopment and commercialization of pharmaceuticals; Computer software for data warehousing for use in the fields of clinical patient careto identify and assign patient to a similar cohort of patients for the purpose of prediction and recommending options available to such patients based on the outcomes observed from patients in the cohort

Classe 42

Design and development of computer software for providing a data warehouse in the fields of biomedical research and healthcare informatics; providing an online computer database in the fields of biopharmaceutical and healthcare informatics relating to data warehousingdata miningdata encryptiondata mapping and electronic data storage; Consultingadvisory and information services in the field of use of data warehousingelectronic data storage and design and development of data warehousing systems relating to clinical and operational comparative patientsyndromehealthcare systems performance data for discoverydevelopment and commercialization of pharmaceuticals; data warehousing in the fields of biopharmaceuticals and healthcare informaticsuse of a database to identify a population of patients who are most similar to a single patient being seen at the point of care in order to assist and enable prediction of the patient's needs and potential outcomes by assigning the single patient to the similar patient cohort identified in the data warehouse; consulting services in the fields of biopharmaceuticals and healthcare informatics relating to data warehousingdata miningdata encryptiondata mapping and electronic data storage; scientific research and development in the fields of biopharmaceuticals and healthcare informatics via a database featuring inputting and collection of data and information used for discoverydevelopments and commercialization of pharmaceuticals

Publicações

Histórico de despachos e eventos da marca no USPTO.

40 publicações encontradas

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

17/01/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/11/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/11/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/11/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/11/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/11/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/07/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/07/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/07/2023

E815

TEAS SECTION 8 & 15 RECEIVED

16/01/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

17/01/2022

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

29/08/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

17/01/2017

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

13/12/2016

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/12/2016

SUPC

STATEMENT OF USE PROCESSING COMPLETE

19/11/2016

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

19/11/2016

IUAF

USE AMENDMENT FILED

03/11/2016

EISU

TEAS STATEMENT OF USE RECEIVED

03/11/2016

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

31/05/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/04/2016

PUBO

PUBLISHED FOR OPPOSITION

05/04/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

16/03/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/02/2016

XAEC

EXAMINER'S AMENDMENT ENTERED

08/02/2016

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/02/2016

GNEA

EXAMINERS AMENDMENT E-MAILED

08/02/2016

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/02/2016

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

04/02/2016

GNFR

FINAL REFUSAL E-MAILED

04/02/2016

CNFR

FINAL REFUSAL WRITTEN

04/02/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/01/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/01/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/01/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

20/12/2015

GNRT

NON-FINAL ACTION E-MAILED

20/12/2015

CNRT

NON-FINAL ACTION WRITTEN

20/12/2015

DOCK

ASSIGNED TO EXAMINER

14/12/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/09/2015

NWAP

NEW APPLICATION ENTERED

03/09/2015

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ORIEN AVATAR ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.